Head-to-head · Cost-Efficiency Index
bmiMD vs PlexusDx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
bmiMD
Price-driven shoppers who want both molecules cheap and nationwide, with a real month-to-month option if they don't want to prepay a year.
Visit bmiMDPlexusDx
Shoppers who want a published starting price with an oral semaglutide option, all 50 states.
Visit PlexusDxThe verdict
bmiMD and PlexusDx tie on the Cost-Efficiency Index at 82/100, so neither wins outright on the numbers. For most shoppers we'd start with bmiMD (ranked #20, a hair above #27) — Price-driven shoppers who want both molecules cheap and nationwide, with a real month-to-month option if they don't want to prepay a year. But PlexusDx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs bmiMD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | bmiMD | PlexusDx |
|---|---|---|
| Cost-Efficiency Index | 82/100 | 82/100 |
| Semaglutide / mo | $129/mo (true month-to-month; $99/mo requires 12-mo prepay) | $149/mo (all doses, compounded) |
| Tirzepatide / mo | $179/mo (true month-to-month; $139/mo requires 12-mo prepay) | $249/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $1,548 | $1,788 |
| Tirzepatide / yr (modeled) | $2,148 | $2,988 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #20 | #27 |
bmiMD
82/100Where the value is
- Low prices on both molecules even month-to-month — $129 semaglutide / $179 tirzepatide, with no dose-based escalation
- A genuine no-commitment month-to-month option exists alongside the cheaper prepay tiers, unlike sites that gate pricing entirely behind a term
- Nationwide all-50 access with both molecules disclosed
The tradeoffs
- The advertised $99/$139 headline requires a full 12-month prepay ($1,188/$1,668 paid upfront) — the true month-to-month rate is 29-30% higher
- Compounded only — no oral or brand option
PlexusDx
82/100Where the value is
- LegitScript Certified, stated directly on the homepage
- Both injection and oral tablet formats for semaglutide from the same starting price
- All 50 states served
The tradeoffs
- 'Starts at' pricing — the page does not disclose what higher doses cost, so $149/$249 is a floor, not what most patients settling into a maintenance dose will pay
- No named prescriber, medical director, or specific compounding pharmacy
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.